The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality
Open accessAbstract
Objective. Previous studies examining opioid dose and overdose risk provide limited granularity by milligram strength and instead rely on thresholds. We quantify dose-dependent overdose mortality over a large spectrum of clinically common doses. We also examine the contributions of benzodiazepines and extended release opioid formulations to mortality. Design. Prospective observational cohort with one year follow-up. Setting. One year in one state (NC) using a controlled substances prescription monitoring program, with name-linked mortality data. Subjects. Residential population of North Carolina (n = 9,560,234), with 2,182,374 opioid analgesic patients. Methods. Exposure was dispensed prescriptions of solid oral and transdermal opioid analgesics; person-years calculated using intent-to-treat principles. Outcome was overdose deaths involving opioid analgesics in a primary or additive role. Poisson models were created, implemented using generalized estimating equations. Results. Opioid analgesics were dispensed to 22.8% of residents. Among licensed clinicians, 89.6% prescribed opioid analgesics, and 40.0% prescribed ER formulations. There were 629 overdose deaths, half of which had an opioid analgesic prescription active on the day of death. Of 2,182,374 patients prescribed opioids, 478 overdose deaths were reported (0.022% per year). Mortality rates increased gradually across the range of average daily milligrams of morphine equivalents. 80.0% of opioid analgesic patients also received benzodiazepines. Rates of overdose death among those co-dispensed benzodiazepines and opioid analgesics were ten times higher (7.0 per 10,000 person-years, 95 percent CI: 6.3, 7.8) than opioid analgesics alone (0.7 per 10,000 person years, 95 percent CI: 0.6, 0.9). Conclusions. Dose-dependent opioid overdose risk among patients increased gradually and did not show evidence of a distinct risk threshold. There is urgent need for guidance about combined classes of medicines to facilitate a better balance between pain relief and overdose risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Opioids for the management of breakthrough (episodic) pain in cancer patients
Zeppetella, G., & Ribeiro, M. D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004311.pub2 · Cited by 156
RetractedRegression standard errors in clustered samples
Rogers, W. H. (1993) · Stata technical bulletin · Cited by 2,694
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
Simon, L. S. (2012) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2012.678473 · Cited by 2,183
Generalized Estimating Equations
Hardin, J. W., & Hilbe, J. M. (2002) · doi:10.1201/9781420035285 · Cited by 1,766
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,529
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Bohnert, A. S. B. (2011) · JAMA · doi:10.1001/jama.2011.370 · Cited by 1,509
Opioid Prescriptions for Chronic Pain and Overdose: A Cohort Study
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta-Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,255
The ‘risk environment’: A framework for understanding and reducing drug-related harm
Rhodes, T. (2002) · International Journal of Drug Policy · doi:10.1016/s0955-3959(02)00007-5 · Cited by 1,241
Risk environments and drug harms: a social science for harm reduction approach
Rhodes, T. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2008.10.003 · Cited by 948
Generalized Linear Models and Extensions
Hardin, J. W., & Hilbe, J. M. (2012) · Cited by 849
Cited by
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Brat, G. A., Agniel, D., Beam, A., Yorkgitis, B., Bicket, M., Homer, M., Fox, K. P., Knecht, D. B., McMahill-Walraven, C. N., Palmer, N., et al. (2018) · BMJ · doi:10.1136/bmj.j5790 · Cited by 591
Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017) · BMJ · doi:10.1136/bmj.j760 · Cited by 534
Risk Factors for Opioid-Use Disorder and Overdose
Webster, L. R. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002496 · Cited by 498
Brandow, A. M., Carroll, C. P., Creary, S., Edwards-Elliott, R., Glassberg, J., Hurley, R. W., Kutlar, A., Seisa, M., Stinson, J., Strouse, J. J., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001851 · Cited by 456
Manchikanti, L. (2017) · Pain Physician · doi:10.36076/ppj.2017.s92 · Cited by 430
Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002−2014
Hwang, C. S., Kang, E. M., Kornegay, C. J., Staffa, J. A., Jones, C. M., & McAninch, J. K. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.02.014 · Cited by 190
Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014.
Hirschtritt, M. E., Delucchi, K. L., & Olfson, M. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.12.010 · Cited by 93
Chua, K.-P., Brummett, C. M., Conti, R. M., & Bohnert, A. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.4878 · Cited by 90
Baldo, B. A. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00314.2024 · Cited by 25
Hernandez, N. M., Cunningham, D. J., Hinton, Z. W., Wu, C. J., & Seyler, T. M. (2021) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.12.004 · Cited by 17
Concomitant Use of Opioids and Benzodiazepines in the Outpatient Setting
Simon, J., Gehret, J., Stolzenberg, D., Beredjiklian, P. K., Teng, J., Paskey, T., & Raju, R. (2019) · PM&R · doi:10.1016/j.pmrj.2018.09.026 · Cited by 8
Benzodiazepine Withdrawal: Clinical Aspects
Wright, S. L. (2020) · The Benzodiazepines Crisis · doi:10.1093/med/9780197517277.003.0008 · Cited by 7
Metadata
- Authors
- Dasgupta, N., Funk, M. J., Proescholdbell, S., Hirsch, A., Ribisl, K. M., & Marshall, S.
- Venue
- Pain Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-01
- Volume
- 17
- Issue
- 1
- Pages
- 85-98
- ISSN
- 1526-2375 (ISSN-L)
- 1526-4637
- OpenAlex
- W1918215063
- Cited by
- 317
- References
- 62
- FWCI
- 28.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.